Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 May 1;323(Pt 3):577–591. doi: 10.1042/bj3230577

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

M L Billingsley 1, R L Kincaid 1
PMCID: PMC1218358  PMID: 9169588

Abstract

This review attempts to summarize what is known about tau phosphorylation in the context of both normal cellular function and dysfunction. However, conceptions of tau function continue to evolve, and it is likely that the regulation of tau distribution and metabolism is complex. The roles of microtubule-associated kinases and phosphatases have yet to be fully described, but may afford insight into how tau phosphorylation at the distal end of the axon regulates cytoskeletal-membrane interactions. Finally, lipid and glycosaminoglycan modification of tau structure affords yet more complexity for regulation and aggregation. Continued work will help to determine what is causal and what is coincidental in Alzheimer's disease, and may lead to identification of therapeutic targets for halting the progression of paired helical filament formation.

Full Text

The Full Text of this article is available as a PDF (380.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Ghany M., el-Sebae A. K., Shalloway D. Aluminum-induced nonenzymatic phospho-incorporation into human tau and other proteins. J Biol Chem. 1993 Jun 5;268(16):11976–11981. [PubMed] [Google Scholar]
  2. Allende J. E., Allende C. C. Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J. 1995 Mar;9(5):313–323. doi: 10.1096/fasebj.9.5.7896000. [DOI] [PubMed] [Google Scholar]
  3. Alonso A. C., Zaidi T., Grundke-Iqbal I., Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5562–5566. doi: 10.1073/pnas.91.12.5562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arendt T., Holzer M., Fruth R., Brückner M. K., Gärtner U. Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience. 1995 Dec;69(3):691–698. doi: 10.1016/0306-4522(95)00347-l. [DOI] [PubMed] [Google Scholar]
  5. Arendt T., Holzer M., Grossmann A., Zedlick D., Brückner M. K. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience. 1995 Sep;68(1):5–18. doi: 10.1016/0306-4522(95)00146-a. [DOI] [PubMed] [Google Scholar]
  6. Arioka M., Tsukamoto M., Ishiguro K., Kato R., Sato K., Imahori K., Uchida T. Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. J Neurochem. 1993 Feb;60(2):461–468. doi: 10.1111/j.1471-4159.1993.tb03173.x. [DOI] [PubMed] [Google Scholar]
  7. Avila J. Microtubule dynamics. FASEB J. 1990 Dec;4(15):3284–3290. doi: 10.1096/fasebj.4.15.2253844. [DOI] [PubMed] [Google Scholar]
  8. Barlow S., Gonzalez-Garay M. L., West R. R., Olmsted J. B., Cabral F. Stable expression of heterologous microtubule-associated proteins (MAPs) in Chinese hamster ovary cells: evidence for differing roles of MAPs in microtubule organization. J Cell Biol. 1994 Aug;126(4):1017–1029. doi: 10.1083/jcb.126.4.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Baudier J., Cole R. D. Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J Biol Chem. 1987 Dec 25;262(36):17577–17583. [PubMed] [Google Scholar]
  10. Baudier J., Lee S. H., Cole R. D. Separation of the different microtubule-associated tau protein species from bovine brain and their mode II phosphorylation by Ca2+/phospholipid-dependent protein kinase C. J Biol Chem. 1987 Dec 25;262(36):17584–17590. [PubMed] [Google Scholar]
  11. Baumann K., Mandelkow E. M., Biernat J., Piwnica-Worms H., Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993 Dec 28;336(3):417–424. doi: 10.1016/0014-5793(93)80849-p. [DOI] [PubMed] [Google Scholar]
  12. Bednarski E., Lynch G. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J Neurochem. 1996 Nov;67(5):1846–1855. doi: 10.1046/j.1471-4159.1996.67051846.x. [DOI] [PubMed] [Google Scholar]
  13. Bennett D. A., Cochran E. J., Saper C. B., Leverenz J. B., Gilley D. W., Wilson R. S. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol Aging. 1993 Nov-Dec;14(6):589–596. doi: 10.1016/0197-4580(93)90043-b. [DOI] [PubMed] [Google Scholar]
  14. Benzing W. C., Mufson E. J. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease. Exp Neurol. 1995 Apr;132(2):162–171. doi: 10.1016/0014-4886(95)90021-7. [DOI] [PubMed] [Google Scholar]
  15. Biernat J., Gustke N., Drewes G., Mandelkow E. M., Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 1993 Jul;11(1):153–163. doi: 10.1016/0896-6273(93)90279-z. [DOI] [PubMed] [Google Scholar]
  16. Billingsley M. L., Ellis C., Kincaid R. L., Martin J., Schmidt M. L., Lee V. M., Trojanowski J. Q. Calcineurin immunoreactivity in Alzheimer's disease. Exp Neurol. 1994 Apr;126(2):178–184. doi: 10.1006/exnr.1994.1056. [DOI] [PubMed] [Google Scholar]
  17. Black M. M., Slaughter T., Moshiach S., Obrocka M., Fischer I. Tau is enriched on dynamic microtubules in the distal region of growing axons. J Neurosci. 1996 Jun 1;16(11):3601–3619. doi: 10.1523/JNEUROSCI.16-11-03601.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Blumenthal D. K., Takio K., Hansen R. S., Krebs E. G. Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity. J Biol Chem. 1986 Jun 25;261(18):8140–8145. [PubMed] [Google Scholar]
  19. Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q., Lee V. M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 1993 Jun;10(6):1089–1099. doi: 10.1016/0896-6273(93)90057-x. [DOI] [PubMed] [Google Scholar]
  20. Brandt R., Lee G. Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro. J Biol Chem. 1993 Feb 15;268(5):3414–3419. [PubMed] [Google Scholar]
  21. Brandt R., Lee G. The balance between tau protein's microtubule growth and nucleation activities: implications for the formation of axonal microtubules. J Neurochem. 1993 Sep;61(3):997–1005. doi: 10.1111/j.1471-4159.1993.tb03613.x. [DOI] [PubMed] [Google Scholar]
  22. Brandt R., Léger J., Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol. 1995 Dec;131(5):1327–1340. doi: 10.1083/jcb.131.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Brion J. P., Hanger D. P., Couck A. M., Anderton B. H. A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Biochem J. 1991 Nov 1;279(Pt 3):831–836. doi: 10.1042/bj2790831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Brion J. P., Octave J. N., Couck A. M. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience. 1994 Dec;63(3):895–909. doi: 10.1016/0306-4522(94)90533-9. [DOI] [PubMed] [Google Scholar]
  25. Brion J. P., Smith C., Couck A. M., Gallo J. M., Anderton B. H. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem. 1993 Dec;61(6):2071–2080. doi: 10.1111/j.1471-4159.1993.tb07444.x. [DOI] [PubMed] [Google Scholar]
  26. Burack M. A., Halpain S. Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons. Neuroscience. 1996 May;72(1):167–184. doi: 10.1016/0306-4522(95)00546-3. [DOI] [PubMed] [Google Scholar]
  27. Busciglio J., Lorenzo A., Yeh J., Yankner B. A. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 1995 Apr;14(4):879–888. doi: 10.1016/0896-6273(95)90232-5. [DOI] [PubMed] [Google Scholar]
  28. Busciglio J., Yankner B. A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995 Dec 21;378(6559):776–779. doi: 10.1038/378776a0. [DOI] [PubMed] [Google Scholar]
  29. Butner K. A., Kirschner M. W. Tau protein binds to microtubules through a flexible array of distributed weak sites. J Cell Biol. 1991 Nov;115(3):717–730. doi: 10.1083/jcb.115.3.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Caceres A., Kosik K. S. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature. 1990 Feb 1;343(6257):461–463. doi: 10.1038/343461a0. [DOI] [PubMed] [Google Scholar]
  31. Callahan C. A., Thomas J. B. Tau-beta-galactosidase, an axon-targeted fusion protein. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5972–5976. doi: 10.1073/pnas.91.13.5972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Chiang M. F., Liu W. K., Yen S. H. Reversible heat stress-related loss of phosphorylated Alzheimer-type epitopes in Tau proteins of human neuroblastoma cells. J Neurosci. 1993 Nov;13(11):4854–4860. doi: 10.1523/JNEUROSCI.13-11-04854.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Cleveland D. W., Hwo S. Y., Kirschner M. W. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol. 1977 Oct 25;116(2):207–225. doi: 10.1016/0022-2836(77)90213-3. [DOI] [PubMed] [Google Scholar]
  34. Cressman C. M., Shea T. B. Hyperphosphorylation of Tau and filopodial retraction following microinjection of protein kinase C catalytic subunits. J Neurosci Res. 1995 Dec;42(5):648–656. doi: 10.1002/jnr.490420507. [DOI] [PubMed] [Google Scholar]
  35. Crutcher K. A., Anderton B. H., Barger S. W., Ohm T. G., Snow A. D. Cellular and molecular pathology in Alzheimer's disease. Hippocampus. 1993;3(Spec No):271–287. [PubMed] [Google Scholar]
  36. Davis D. R., Brion J. P., Couck A. M., Gallo J. M., Hanger D. P., Ladhani K., Lewis C., Miller C. C., Rupniak T., Smith C. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem J. 1995 Aug 1;309(Pt 3):941–949. doi: 10.1042/bj3090941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Dawson T. M., Steiner J. P., Dawson V. L., Dinerman J. L., Uhl G. R., Snyder S. H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9808–9812. doi: 10.1073/pnas.90.21.9808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Doering L. C. Probing modifications of the neuronal cytoskeleton. Mol Neurobiol. 1993 Fall-Winter;7(3-4):265–291. doi: 10.1007/BF02769179. [DOI] [PubMed] [Google Scholar]
  39. Dorée M., Galas S. The cyclin-dependent protein kinases and the control of cell division. FASEB J. 1994 Nov;8(14):1114–1121. doi: 10.1096/fasebj.8.14.7958616. [DOI] [PubMed] [Google Scholar]
  40. Drewes G., Lichtenberg-Kraag B., Döring F., Mandelkow E. M., Biernat J., Goris J., Dorée M., Mandelkow E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 1992 Jun;11(6):2131–2138. doi: 10.1002/j.1460-2075.1992.tb05272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Drewes G., Mandelkow E. M., Baumann K., Goris J., Merlevede W., Mandelkow E. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A. FEBS Lett. 1993 Dec 28;336(3):425–432. doi: 10.1016/0014-5793(93)80850-t. [DOI] [PubMed] [Google Scholar]
  42. Drewes G., Trinczek B., Illenberger S., Biernat J., Schmitt-Ulms G., Meyer H. E., Mandelkow E. M., Mandelkow E. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J Biol Chem. 1995 Mar 31;270(13):7679–7688. doi: 10.1074/jbc.270.13.7679. [DOI] [PubMed] [Google Scholar]
  43. Dudek S. M., Johnson G. V. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J Neurochem. 1993 Sep;61(3):1159–1162. doi: 10.1111/j.1471-4159.1993.tb03636.x. [DOI] [PubMed] [Google Scholar]
  44. Dupont-Wallois L., Sautière P. E., Cocquerelle C., Bailleul B., Delacourte A., Caillet-Boudin M. L. Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. FEBS Lett. 1995 Jan 3;357(2):197–201. doi: 10.1016/0014-5793(94)01361-4. [DOI] [PubMed] [Google Scholar]
  45. Feany M. B., Dickson D. W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol. 1996 Aug;40(2):139–148. doi: 10.1002/ana.410400204. [DOI] [PubMed] [Google Scholar]
  46. Ferreira A., Kincaid R., Kosik K. S. Calcineurin is associated with the cytoskeleton of cultured neurons and has a role in the acquisition of polarity. Mol Biol Cell. 1993 Dec;4(12):1225–1238. doi: 10.1091/mbc.4.12.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fleming L. M., Johnson G. V. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem J. 1995 Jul 1;309(Pt 1):41–47. doi: 10.1042/bj3090041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Fleming L. M., Weisgraber K. H., Strittmatter W. J., Troncoso J. C., Johnson G. V. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp Neurol. 1996 Apr;138(2):252–260. doi: 10.1006/exnr.1996.0064. [DOI] [PubMed] [Google Scholar]
  49. Garver T. D., Harris K. A., Lehman R. A., Lee V. M., Trojanowski J. Q., Billingsley M. L. Tau phosphorylation in human, primate, and rat brain: evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro. J Neurochem. 1994 Dec;63(6):2279–2287. doi: 10.1046/j.1471-4159.1994.63062279.x. [DOI] [PubMed] [Google Scholar]
  50. Garver T. D., Lehman R. A., Billingsley M. L. Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau. J Neurosci Res. 1996 Apr 1;44(1):12–20. doi: 10.1002/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  51. Garver T. D., Oyler G. A., Harris K. A., Polavarapu R., Damuni Z., Lehman R. A., Billingsley M. L. Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase. Mol Pharmacol. 1995 Apr;47(4):745–756. [PubMed] [Google Scholar]
  52. Geerts H., Nuydens R., Nuyens R., Cornelissen F., De Brabander M., Pauwels P., Janssen P. A., Song Y. H., Mandelkow E. M. Sabeluzole, a memory-enhancing molecule, increases fast axonal transport in neuronal cell cultures. Exp Neurol. 1992 Jul;117(1):36–43. doi: 10.1016/0014-4886(92)90108-3. [DOI] [PubMed] [Google Scholar]
  53. Goedert M., Cohen E. S., Jakes R., Cohen P. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected]. FEBS Lett. 1992 Nov 2;312(1):95–99. doi: 10.1016/0014-5793(92)81418-l. [DOI] [PubMed] [Google Scholar]
  54. Goedert M., Jakes R., Crowther R. A., Cohen P., Vanmechelen E., Vandermeeren M., Cras P. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J. 1994 Aug 1;301(Pt 3):871–877. doi: 10.1042/bj3010871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Goedert M., Jakes R., Crowther R. A., Six J., Lübke U., Vandermeeren M., Cras P., Trojanowski J. Q., Lee V. M. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5066–5070. doi: 10.1073/pnas.90.11.5066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 1990 Dec;9(13):4225–4230. doi: 10.1002/j.1460-2075.1990.tb07870.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Goedert M., Jakes R., Spillantini M. G., Hasegawa M., Smith M. J., Crowther R. A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature. 1996 Oct 10;383(6600):550–553. doi: 10.1038/383550a0. [DOI] [PubMed] [Google Scholar]
  58. Goedert M., Spillantini M. G., Cairns N. J., Crowther R. A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 1992 Jan;8(1):159–168. doi: 10.1016/0896-6273(92)90117-v. [DOI] [PubMed] [Google Scholar]
  59. Goedert M., Spillantini M. G., Crowther R. A. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1983–1987. doi: 10.1073/pnas.89.5.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Goedert M., Spillantini M. G., Jakes R., Crowther R. A., Vanmechelen E., Probst A., Götz J., Bürki K., Cohen P. Molecular dissection of the paired helical filament. Neurobiol Aging. 1995 May-Jun;16(3):325–334. doi: 10.1016/0197-4580(95)00017-9. [DOI] [PubMed] [Google Scholar]
  61. Goedert M., Spillantini M. G., Jakes R., Rutherford D., Crowther R. A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 1989 Oct;3(4):519–526. doi: 10.1016/0896-6273(89)90210-9. [DOI] [PubMed] [Google Scholar]
  62. Goedert M., Spillantini M. G., Jakes R., Rutherford D., Crowther R. A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 1989 Oct;3(4):519–526. doi: 10.1016/0896-6273(89)90210-9. [DOI] [PubMed] [Google Scholar]
  63. Goedert M., Wischik C. M., Crowther R. A., Walker J. E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A. 1988 Jun;85(11):4051–4055. doi: 10.1073/pnas.85.11.4051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Gong C. X., Grundke-Iqbal I., Damuni Z., Iqbal K. Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett. 1994 Mar 14;341(1):94–98. doi: 10.1016/0014-5793(94)80247-5. [DOI] [PubMed] [Google Scholar]
  65. Gong C. X., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience. 1994 Aug;61(4):765–772. doi: 10.1016/0306-4522(94)90400-6. [DOI] [PubMed] [Google Scholar]
  66. Gong C. X., Shaikh S., Wang J. Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem. 1995 Aug;65(2):732–738. doi: 10.1046/j.1471-4159.1995.65020732.x. [DOI] [PubMed] [Google Scholar]
  67. Gong C. X., Singh T. J., Grundke-Iqbal I., Iqbal K. Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J Neurochem. 1994 Feb;62(2):803–806. doi: 10.1046/j.1471-4159.1994.62020803.x. [DOI] [PubMed] [Google Scholar]
  68. Gong C. X., Singh T. J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem. 1993 Sep;61(3):921–927. doi: 10.1111/j.1471-4159.1993.tb03603.x. [DOI] [PubMed] [Google Scholar]
  69. Goto S., Yamamoto H., Fukunaga K., Iwasa T., Matsukado Y., Miyamoto E. Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by calcineurin. J Neurochem. 1985 Jul;45(1):276–283. doi: 10.1111/j.1471-4159.1985.tb05504.x. [DOI] [PubMed] [Google Scholar]
  70. Goux W. J., Rodriguez S., Sparkman D. R. Characterization of the glycolipid associated with Alzheimer paired helical filaments. J Neurochem. 1996 Aug;67(2):723–733. doi: 10.1046/j.1471-4159.1996.67020723.x. [DOI] [PubMed] [Google Scholar]
  71. Greenberg S. M., Koo E. H., Selkoe D. J., Qiu W. Q., Kosik K. S. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7104–7108. doi: 10.1073/pnas.91.15.7104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y. C., Zaidi M. S., Wisniewski H. M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem. 1986 May 5;261(13):6084–6089. [PubMed] [Google Scholar]
  73. Gustke N., Steiner B., Mandelkow E. M., Biernat J., Meyer H. E., Goedert M., Mandelkow E. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett. 1992 Jul 28;307(2):199–205. doi: 10.1016/0014-5793(92)80767-b. [DOI] [PubMed] [Google Scholar]
  74. Gustke N., Trinczek B., Biernat J., Mandelkow E. M., Mandelkow E. Domains of tau protein and interactions with microtubules. Biochemistry. 1994 Aug 16;33(32):9511–9522. doi: 10.1021/bi00198a017. [DOI] [PubMed] [Google Scholar]
  75. Guttmann R. P., Erickson A. C., Johnson G. V. Tau self-association: stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state. J Neurochem. 1995 Mar;64(3):1209–1215. doi: 10.1046/j.1471-4159.1995.64031209.x. [DOI] [PubMed] [Google Scholar]
  76. Hamill R. W., Markesbery W. R., McDaniel K., Coleman P. D. Characterization of brain samples in studies of aging, Alzheimer's, and other neurodegenerative diseases. Neurobiol Aging. 1993 Nov-Dec;14(6):539–545. doi: 10.1016/0197-4580(93)90037-c. [DOI] [PubMed] [Google Scholar]
  77. Haque N., Denman R. B., Merz G., Grundke-Iqbal I., Iqbal K. Phosphorylation and accumulation of tau without any concomitant increase in tubulin levels in Chinese hamster ovary cells stably transfected with human tau441. FEBS Lett. 1995 Feb 27;360(2):132–136. doi: 10.1016/0014-5793(95)00089-r. [DOI] [PubMed] [Google Scholar]
  78. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshitake R., Takei Y., Noda T., Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature. 1994 Jun 9;369(6480):488–491. doi: 10.1038/369488a0. [DOI] [PubMed] [Google Scholar]
  79. Harris K. A., Oyler G. A., Doolittle G. M., Vincent I., Lehman R. A., Kincaid R. L., Billingsley M. L. Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices. Ann Neurol. 1993 Jan;33(1):77–87. doi: 10.1002/ana.410330113. [DOI] [PubMed] [Google Scholar]
  80. Hasegawa M., Morishima-Kawashima M., Takio K., Suzuki M., Titani K., Ihara Y. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J Biol Chem. 1992 Aug 25;267(24):17047–17054. [PubMed] [Google Scholar]
  81. Himmler A., Drechsel D., Kirschner M. W., Martin D. W., Jr Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol Cell Biol. 1989 Apr;9(4):1381–1388. doi: 10.1128/mcb.9.4.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Hirokawa N. Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol. 1994 Feb;6(1):74–81. doi: 10.1016/0955-0674(94)90119-8. [DOI] [PubMed] [Google Scholar]
  83. Hisanaga S., Ishiguro K., Uchida T., Okumura E., Okano T., Kishimoto T. Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins. J Biol Chem. 1993 Jul 15;268(20):15056–15060. [PubMed] [Google Scholar]
  84. Ho D. T., Shayan H., Murphy T. H. Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation. J Neurochem. 1997 Jan;68(1):106–111. doi: 10.1046/j.1471-4159.1997.68010106.x. [DOI] [PubMed] [Google Scholar]
  85. Holzer M., Holzapfel H. P., Zedlick D., Brückner M. K., Arendt T. Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience. 1994 Nov;63(2):499–516. doi: 10.1016/0306-4522(94)90546-0. [DOI] [PubMed] [Google Scholar]
  86. Hoshi M., Nishida E., Miyata Y., Sakai H., Miyoshi T., Ogawara H., Akiyama T. Protein kinase C phosphorylates tau and induces its functional alterations. FEBS Lett. 1987 Jun 15;217(2):237–241. doi: 10.1016/0014-5793(87)80670-1. [DOI] [PubMed] [Google Scholar]
  87. Inagaki N., Ito M., Nakano T., Inagaki M. Spatiotemporal distribution of protein kinase and phosphatase activities. Trends Biochem Sci. 1994 Nov;19(11):448–452. doi: 10.1016/0968-0004(94)90128-7. [DOI] [PubMed] [Google Scholar]
  88. Iqbal K., Grundke-Iqbal I. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Mol Neurobiol. 1991;5(2-4):399–410. doi: 10.1007/BF02935561. [DOI] [PubMed] [Google Scholar]
  89. Ishiguro K., Kobayashi S., Omori A., Takamatsu M., Yonekura S., Anzai K., Imahori K., Uchida T. Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS Lett. 1994 Apr 4;342(2):203–208. doi: 10.1016/0014-5793(94)80501-6. [DOI] [PubMed] [Google Scholar]
  90. Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., Imahori K. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem. 1992 May 25;267(15):10897–10901. [PubMed] [Google Scholar]
  91. Iversen L. L., Mortishire-Smith R. J., Pollack S. J., Shearman M. S. The toxicity in vitro of beta-amyloid protein. Biochem J. 1995 Oct 1;311(Pt 1):1–16. doi: 10.1042/bj3110001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Johnson G. V. Differential phosphorylation of tau by cyclic AMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase II: metabolic and functional consequences. J Neurochem. 1992 Dec;59(6):2056–2062. doi: 10.1111/j.1471-4159.1992.tb10094.x. [DOI] [PubMed] [Google Scholar]
  93. Kanai Y., Hirokawa N. Sorting mechanisms of tau and MAP2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding. Neuron. 1995 Feb;14(2):421–432. doi: 10.1016/0896-6273(95)90298-8. [DOI] [PubMed] [Google Scholar]
  94. Kanemaru K., Takio K., Miura R., Titani K., Ihara Y. Fetal-type phosphorylation of the tau in paired helical filaments. J Neurochem. 1992 May;58(5):1667–1675. doi: 10.1111/j.1471-4159.1992.tb10039.x. [DOI] [PubMed] [Google Scholar]
  95. Kempf M., Clement A., Faissner A., Lee G., Brandt R. Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J Neurosci. 1996 Sep 15;16(18):5583–5592. doi: 10.1523/JNEUROSCI.16-18-05583.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Kincaid R. L., Giri P. R., Higuchi S., Tamura J., Dixon S. C., Marietta C. A., Amorese D. A., Martin B. M. Cloning and characterization of molecular isoforms of the catalytic subunit of calcineurin using nonisotopic methods. J Biol Chem. 1990 Jul 5;265(19):11312–11319. [PubMed] [Google Scholar]
  97. Knops J., Kosik K. S., Lee G., Pardee J. D., Cohen-Gould L., McConlogue L. Overexpression of tau in a nonneuronal cell induces long cellular processes. J Cell Biol. 1991 Aug;114(4):725–733. doi: 10.1083/jcb.114.4.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Kosik K. S. Alzheimer's disease: a cell biological perspective. Science. 1992 May 8;256(5058):780–783. doi: 10.1126/science.1589757. [DOI] [PubMed] [Google Scholar]
  99. Kosik K. S., Joachim C. L., Selkoe D. J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A. 1986 Jun;83(11):4044–4048. doi: 10.1073/pnas.83.11.4044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Kosik K. S., Orecchio L. D., Bakalis S., Neve R. L. Developmentally regulated expression of specific tau sequences. Neuron. 1989 Apr;2(4):1389–1397. doi: 10.1016/0896-6273(89)90077-9. [DOI] [PubMed] [Google Scholar]
  101. Kosik K. S., Orecchio L. D., Binder L., Trojanowski J. Q., Lee V. M., Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron. 1988 Nov;1(9):817–825. doi: 10.1016/0896-6273(88)90129-8. [DOI] [PubMed] [Google Scholar]
  102. Kosik K. S. The Alzheimer's disease sphinx: a riddle with plaques and tangles. J Cell Biol. 1994 Dec;127(6 Pt 1):1501–1504. doi: 10.1083/jcb.127.6.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Kuno T., Mukai H., Ito A., Chang C. D., Kishima K., Saito N., Tanaka C. Distinct cellular expression of calcineurin A alpha and A beta in rat brain. J Neurochem. 1992 May;58(5):1643–1651. doi: 10.1111/j.1471-4159.1992.tb10036.x. [DOI] [PubMed] [Google Scholar]
  104. Köpke E., Tung Y. C., Shaikh S., Alonso A. C., Iqbal K., Grundke-Iqbal I. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem. 1993 Nov 15;268(32):24374–24384. [PubMed] [Google Scholar]
  105. Ledesma M. D., Avila J., Correas I. Isolation of a phosphorylated soluble tau fraction from Alzheimer's disease brain. Neurobiol Aging. 1995 Jul-Aug;16(4):515–522. doi: 10.1016/0197-4580(95)00075-p. [DOI] [PubMed] [Google Scholar]
  106. Ledesma M. D., Bonay P., Avila J. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem. 1995 Oct;65(4):1658–1664. doi: 10.1046/j.1471-4159.1995.65041658.x. [DOI] [PubMed] [Google Scholar]
  107. Ledesma M. D., Bonay P., Colaço C., Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem. 1994 Aug 26;269(34):21614–21619. [PubMed] [Google Scholar]
  108. Lee G., Cowan N., Kirschner M. The primary structure and heterogeneity of tau protein from mouse brain. Science. 1988 Jan 15;239(4837):285–288. doi: 10.1126/science.3122323. [DOI] [PubMed] [Google Scholar]
  109. Lee V. M., Balin B. J., Otvos L., Jr, Trojanowski J. Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 1991 Feb 8;251(4994):675–678. doi: 10.1126/science.1899488. [DOI] [PubMed] [Google Scholar]
  110. Lew J., Winkfein R. J., Paudel H. K., Wang J. H. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J Biol Chem. 1992 Dec 25;267(36):25922–25926. [PubMed] [Google Scholar]
  111. Li M., Makkinje A., Damuni Z. Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry. 1996 Jun 4;35(22):6998–7002. doi: 10.1021/bi960581y. [DOI] [PubMed] [Google Scholar]
  112. Litersky J. M., Johnson G. V., Jakes R., Goedert M., Lee M., Seubert P. Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem J. 1996 Jun 1;316(Pt 2):655–660. doi: 10.1042/bj3160655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Litersky J. M., Johnson G. V. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J Biol Chem. 1992 Jan 25;267(3):1563–1568. [PubMed] [Google Scholar]
  114. Litersky J. M., Johnson G. V. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J Biol Chem. 1992 Jan 25;267(3):1563–1568. [PubMed] [Google Scholar]
  115. Litersky J. M., Johnson G. V. Phosphorylation of tau in situ: inhibition of calcium-dependent proteolysis. J Neurochem. 1995 Aug;65(2):903–911. doi: 10.1046/j.1471-4159.1995.65020903.x. [DOI] [PubMed] [Google Scholar]
  116. Litman P., Barg J., Ginzburg I. Microtubules are involved in the localization of tau mRNA in primary neuronal cell cultures. Neuron. 1994 Dec;13(6):1463–1474. doi: 10.1016/0896-6273(94)90432-4. [DOI] [PubMed] [Google Scholar]
  117. Litman P., Barg J., Rindzoonski L., Ginzburg I. Subcellular localization of tau mRNA in differentiating neuronal cell culture: implications for neuronal polarity. Neuron. 1993 Apr;10(4):627–638. doi: 10.1016/0896-6273(93)90165-n. [DOI] [PubMed] [Google Scholar]
  118. Liu W. K., Ksiezak-Reding H., Yen S. H. Abnormal tau proteins from Alzheimer's disease brains. Purification and amino acid analysis. J Biol Chem. 1991 Nov 15;266(32):21723–21727. [PubMed] [Google Scholar]
  119. Liu W. K., Yen S. H. The state of phosphorylation of normal adult brain tau, fetal tau, and tau from Alzheimer paired helical filaments at amino acid residue Ser262. J Neurochem. 1996 Mar;66(3):1131–1139. doi: 10.1046/j.1471-4159.1996.66031131.x. [DOI] [PubMed] [Google Scholar]
  120. Lovestone S., Hartley C. L., Pearce J., Anderton B. H. Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience. 1996 Aug;73(4):1145–1157. doi: 10.1016/0306-4522(96)00126-1. [DOI] [PubMed] [Google Scholar]
  121. Lu Q., Soria J. P., Wood J. G. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. J Neurosci Res. 1993 Jul 1;35(4):439–444. doi: 10.1002/jnr.490350411. [DOI] [PubMed] [Google Scholar]
  122. Lu Q., Wood J. G. Functional studies of Alzheimer's disease tau protein. J Neurosci. 1993 Feb;13(2):508–515. doi: 10.1523/JNEUROSCI.13-02-00508.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Mandelkow E. M., Biernat J., Drewes G., Gustke N., Trinczek B., Mandelkow E. Tau domains, phosphorylation, and interactions with microtubules. Neurobiol Aging. 1995 May-Jun;16(3):355–363. doi: 10.1016/0197-4580(95)00025-a. [DOI] [PubMed] [Google Scholar]
  124. Mandelkow E. M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J. R., Mandelkow E. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 1992 Dec 21;314(3):315–321. doi: 10.1016/0014-5793(92)81496-9. [DOI] [PubMed] [Google Scholar]
  125. Mandelkow E., Mandelkow E. M. Microtubules and microtubule-associated proteins. Curr Opin Cell Biol. 1995 Feb;7(1):72–81. doi: 10.1016/0955-0674(95)80047-6. [DOI] [PubMed] [Google Scholar]
  126. Mandelkow E., Song Y. H., Schweers O., Marx A., Mandelkow E. M. On the structure of microtubules, tau, and paired helical filaments. Neurobiol Aging. 1995 May-Jun;16(3):347–354. doi: 10.1016/0197-4580(95)00026-b. [DOI] [PubMed] [Google Scholar]
  127. Martin H., Lambert M. P., Barber K., Hinton S., Klein W. L. Alzheimer's-associated phospho-tau epitope in human neuroblastoma cell cultures: up-regulation by fibronectin and laminin. Neuroscience. 1995 Jun;66(4):769–779. doi: 10.1016/0306-4522(94)00566-n. [DOI] [PubMed] [Google Scholar]
  128. Martzen M. R., Nagy A., Coleman P. D., Zwiers H. Altered phosphorylation of growth-associated protein B50/GAP-43 in Alzheimer disease with high neurofibrillary tangle density. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11187–11191. doi: 10.1073/pnas.90.23.11187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A. D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol. 1995 Dec;136(2):107–122. doi: 10.1006/exnr.1995.1088. [DOI] [PubMed] [Google Scholar]
  130. Matsuo E. S., Shin R. W., Billingsley M. L., Van deVoorde A., O'Connor M., Trojanowski J. Q., Lee V. M. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 1994 Oct;13(4):989–1002. doi: 10.1016/0896-6273(94)90264-x. [DOI] [PubMed] [Google Scholar]
  131. Mattson M. P. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons. Neuron. 1990 Jan;4(1):105–117. doi: 10.1016/0896-6273(90)90447-n. [DOI] [PubMed] [Google Scholar]
  132. Mattson M. P. Effects of microtubule stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons. Brain Res. 1992 Jun 5;582(1):107–118. doi: 10.1016/0006-8993(92)90323-2. [DOI] [PubMed] [Google Scholar]
  133. Mattson M. P., Engle M. G., Rychlik B. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol Chem Neuropathol. 1991 Oct;15(2):117–142. doi: 10.1007/BF03159951. [DOI] [PubMed] [Google Scholar]
  134. Mawal-Dewan M., Henley J., Van de Voorde A., Trojanowski J. Q., Lee V. M. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J Biol Chem. 1994 Dec 9;269(49):30981–30987. [PubMed] [Google Scholar]
  135. Mawal-Dewan M., Sen P. C., Abdel-Ghany M., Shalloway D., Racker E. Phosphorylation of tau protein by purified p34cdc28 and a related protein kinase from neurofilaments. J Biol Chem. 1992 Sep 25;267(27):19705–19709. [PubMed] [Google Scholar]
  136. Merrick S. E., Demoise D. C., Lee V. M. Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J Biol Chem. 1996 Mar 8;271(10):5589–5594. doi: 10.1074/jbc.271.10.5589. [DOI] [PubMed] [Google Scholar]
  137. Miller M. L., Johnson G. V. Transglutaminase cross-linking of the tau protein. J Neurochem. 1995 Oct;65(4):1760–1770. doi: 10.1046/j.1471-4159.1995.65041760.x. [DOI] [PubMed] [Google Scholar]
  138. Miyamoto S., Teramoto H., Coso O. A., Gutkind J. S., Burbelo P. D., Akiyama S. K., Yamada K. M. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol. 1995 Nov;131(3):791–805. doi: 10.1083/jcb.131.3.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Mohit A. A., Martin J. H., Miller C. A. p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron. 1995 Jan;14(1):67–78. doi: 10.1016/0896-6273(95)90241-4. [DOI] [PubMed] [Google Scholar]
  140. Moreno F. J., Medina M., Pérez M., Montejo de Garcini E., Avila J. Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin). FEBS Lett. 1995 Sep 18;372(1):65–68. doi: 10.1016/0014-5793(95)00934-2. [DOI] [PubMed] [Google Scholar]
  141. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Titani K., Ihara Y. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron. 1993 Jun;10(6):1151–1160. doi: 10.1016/0896-6273(93)90063-w. [DOI] [PubMed] [Google Scholar]
  142. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Watanabe A., Titani K., Ihara Y. Hyperphosphorylation of tau in PHF. Neurobiol Aging. 1995 May-Jun;16(3):365–380. doi: 10.1016/0197-4580(95)00027-c. [DOI] [PubMed] [Google Scholar]
  143. Morishima-Kawashima M., Kosik K. S. The pool of map kinase associated with microtubules is small but constitutively active. Mol Biol Cell. 1996 Jun;7(6):893–905. doi: 10.1091/mbc.7.6.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Nathan B. P., Chang K. C., Bellosta S., Brisch E., Ge N., Mahley R. W., Pitas R. E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem. 1995 Aug 25;270(34):19791–19799. doi: 10.1074/jbc.270.34.19791. [DOI] [PubMed] [Google Scholar]
  145. Nelson P. T., Stefansson K., Gulcher J., Saper C. B. Molecular evolution of tau protein: implications for Alzheimer's disease. J Neurochem. 1996 Oct;67(4):1622–1632. doi: 10.1046/j.1471-4159.1996.67041622.x. [DOI] [PubMed] [Google Scholar]
  146. Novak M., Kabat J., Wischik C. M. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 1993 Jan;12(1):365–370. doi: 10.1002/j.1460-2075.1993.tb05665.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Oyama F., Cairns N. J., Shimada H., Oyama R., Titani K., Ihara Y. Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J Neurochem. 1994 Mar;62(3):1062–1066. doi: 10.1046/j.1471-4159.1994.62031062.x. [DOI] [PubMed] [Google Scholar]
  148. Papasozomenos S. C., Su Y. Rapid dephosphorylation of tau in heat-shocked fetal rat cerebral explants: prevention and hyperphosphorylation by inhibitors of protein phosphatases PP1 and PP2A. J Neurochem. 1995 Jul;65(1):396–406. doi: 10.1046/j.1471-4159.1995.65010396.x. [DOI] [PubMed] [Google Scholar]
  149. Parsons J. N., Wiederrecht G. J., Salowe S., Burbaum J. J., Rokosz L. L., Kincaid R. L., O'Keefe S. J. Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex. J Biol Chem. 1994 Jul 29;269(30):19610–19616. [PubMed] [Google Scholar]
  150. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J. 1995 Jun 15;308(Pt 3):697–711. doi: 10.1042/bj3080697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Polli J. W., Billingsley M. L., Kincaid R. L. Expression of the calmodulin-dependent protein phosphatase, calcineurin, in rat brain: developmental patterns and the role of nigrostriatal innervation. Brain Res Dev Brain Res. 1991 Nov 19;63(1-2):105–119. doi: 10.1016/0165-3806(91)90071-p. [DOI] [PubMed] [Google Scholar]
  152. Pope W. B., Lambert M. P., Leypold B., Seupaul R., Sletten L., Krafft G., Klein W. L. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Exp Neurol. 1994 Apr;126(2):185–194. doi: 10.1006/exnr.1994.1057. [DOI] [PubMed] [Google Scholar]
  153. Preuss U., Döring F., Illenberger S., Mandelkow E. M. Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells. Mol Biol Cell. 1995 Oct;6(10):1397–1410. doi: 10.1091/mbc.6.10.1397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Pérez M., Valpuesta J. M., Medina M., Montejo de Garcini E., Avila J. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem. 1996 Sep;67(3):1183–1190. doi: 10.1046/j.1471-4159.1996.67031183.x. [DOI] [PubMed] [Google Scholar]
  155. Quinlan E. M., Halpain S. Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors. Neuron. 1996 Feb;16(2):357–368. doi: 10.1016/s0896-6273(00)80053-7. [DOI] [PubMed] [Google Scholar]
  156. Richey P. L., Siedlak S. L., Smith M. A., Perry G. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Biochem Biophys Res Commun. 1995 Mar 17;208(2):657–663. doi: 10.1006/bbrc.1995.1389. [DOI] [PubMed] [Google Scholar]
  157. Roder H. M., Eden P. A., Ingram V. M. Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease. Biochem Biophys Res Commun. 1993 Jun 15;193(2):639–647. doi: 10.1006/bbrc.1993.1672. [DOI] [PubMed] [Google Scholar]
  158. Roder H. M., Hoffman F. J., Schröder W. Phosphatase resistance of ERK2 brain kinase PK40erk2. J Neurochem. 1995 May;64(5):2203–2212. doi: 10.1046/j.1471-4159.1995.64052203.x. [DOI] [PubMed] [Google Scholar]
  159. Sadot E., Gurwitz D., Barg J., Behar L., Ginzburg I., Fisher A. Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J Neurochem. 1996 Feb;66(2):877–880. doi: 10.1046/j.1471-4159.1996.66020877.x. [DOI] [PubMed] [Google Scholar]
  160. Savory J., Huang Y., Herman M. M., Wills M. R. Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration; non-phosphorylated epitopes precede phosphorylation. Brain Res. 1996 Jan 29;707(2):272–281. doi: 10.1016/0006-8993(95)01264-8. [DOI] [PubMed] [Google Scholar]
  161. Schweers O., Schönbrunn-Hanebeck E., Marx A., Mandelkow E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J Biol Chem. 1994 Sep 30;269(39):24290–24297. [PubMed] [Google Scholar]
  162. Scott C. W., Blowers D. P., Barth P. T., Lo M. M., Salama A. I., Caputo C. B. Differences in the abilities of human tau isoforms to promote microtubule assembly. J Neurosci Res. 1991 Sep;30(1):154–162. doi: 10.1002/jnr.490300116. [DOI] [PubMed] [Google Scholar]
  163. Scott C. W., Klika A. B., Lo M. M., Norris T. E., Caputo C. B. Tau protein induces bundling of microtubules in vitro: comparison of different tau isoforms and a tau protein fragment. J Neurosci Res. 1992 Sep;33(1):19–29. doi: 10.1002/jnr.490330104. [DOI] [PubMed] [Google Scholar]
  164. Selkoe D. J. The molecular pathology of Alzheimer's disease. Neuron. 1991 Apr;6(4):487–498. doi: 10.1016/0896-6273(91)90052-2. [DOI] [PubMed] [Google Scholar]
  165. Seubert P., Mawal-Dewan M., Barbour R., Jakes R., Goedert M., Johnson G. V., Litersky J. M., Schenk D., Lieberburg I., Trojanowski J. Q. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem. 1995 Aug 11;270(32):18917–18922. doi: 10.1074/jbc.270.32.18917. [DOI] [PubMed] [Google Scholar]
  166. Shea T. B., Beermann M. L. Respective roles of neurofilaments, microtubules, MAP1B, and tau in neurite outgrowth and stabilization. Mol Biol Cell. 1994 Aug;5(8):863–875. doi: 10.1091/mbc.5.8.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Shea T. B., Fischer I. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules. FEBS Lett. 1996 Feb 12;380(1-2):63–67. doi: 10.1016/0014-5793(95)01411-x. [DOI] [PubMed] [Google Scholar]
  168. Shea T. B., Spencer M. J., Beermann M. L., Cressman C. M., Nixon R. A. Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J Neurochem. 1996 Apr;66(4):1539–1549. doi: 10.1046/j.1471-4159.1996.66041539.x. [DOI] [PubMed] [Google Scholar]
  169. Shimohama S., Fujimoto S., Taniguchi T., Kameyama M., Kimura J. Reduction of low-molecular-weight acid phosphatase activity in Alzheimer brains. Ann Neurol. 1993 Jun;33(6):616–621. doi: 10.1002/ana.410330610. [DOI] [PubMed] [Google Scholar]
  170. Shin R. W., Lee V. M., Trojanowski J. Q. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro. J Neurosci. 1994 Nov;14(11 Pt 2):7221–7233. doi: 10.1523/JNEUROSCI.14-11-07221.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Sindou P., Couratier P., Barthe D., Hugon J. A dose-dependent increase of Tau immunostaining is produced by glutamate toxicity in primary neuronal cultures. Brain Res. 1992 Feb 14;572(1-2):242–246. doi: 10.1016/0006-8993(92)90476-p. [DOI] [PubMed] [Google Scholar]
  172. Singh T. J., Grundke-Iqbal I., Iqbal K. Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state. J Neurochem. 1995 Mar;64(3):1420–1423. doi: 10.1046/j.1471-4159.1995.64031420.x. [DOI] [PubMed] [Google Scholar]
  173. Singh T. J., Haque N., Grundke-Iqbal I., Iqbal K. Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3. FEBS Lett. 1995 Jan 30;358(3):267–272. doi: 10.1016/0014-5793(94)01445-7. [DOI] [PubMed] [Google Scholar]
  174. Singh T. J., Zaidi T., Grundke-Iqbal I., Iqbal K. Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases. FEBS Lett. 1995 Jan 16;358(1):4–8. doi: 10.1016/0014-5793(94)01383-c. [DOI] [PubMed] [Google Scholar]
  175. Sontag E., Nunbhakdi-Craig V., Lee G., Bloom G. S., Mumby M. C. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron. 1996 Dec;17(6):1201–1207. doi: 10.1016/s0896-6273(00)80250-0. [DOI] [PubMed] [Google Scholar]
  176. Steiner B., Mandelkow E. M., Biernat J., Gustke N., Meyer H. E., Schmidt B., Mieskes G., Söling H. D., Drechsel D., Kirschner M. W. Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. EMBO J. 1990 Nov;9(11):3539–3544. doi: 10.1002/j.1460-2075.1990.tb07563.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Strittmatter W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., Dong L. M., Jakes R., Alberts M. J., Gilbert J. R. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994 Feb;125(2):163–174. doi: 10.1006/exnr.1994.1019. [DOI] [PubMed] [Google Scholar]
  178. Takahashi M., Tomizawa K., Ishiguro K., Takamatsu M., Fujita S. C., Imahori K. Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain. J Neurochem. 1995 Apr;64(4):1759–1768. doi: 10.1046/j.1471-4159.1995.64041759.x. [DOI] [PubMed] [Google Scholar]
  179. Takashima A., Noguchi K., Sato K., Hoshino T., Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7789–7793. doi: 10.1073/pnas.90.16.7789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Takemura R., Kanai Y., Hirokawa N. In situ localization of tau mRNA in developing rat brain. Neuroscience. 1991;44(2):393–407. doi: 10.1016/0306-4522(91)90064-u. [DOI] [PubMed] [Google Scholar]
  181. Tanaka T., Iqbal K., Trenkner E., Liu D. J., Grundke-Iqbal I. Abnormally phosphorylated tau in SY5Y human neuroblastoma cells. FEBS Lett. 1995 Feb 20;360(1):5–9. doi: 10.1016/0014-5793(95)00061-d. [DOI] [PubMed] [Google Scholar]
  182. Tashiro T., Sun X., Tsuda M., Komiya Y. Differential axonal transport of soluble and insoluble tau in the rat sciatic nerve. J Neurochem. 1996 Oct;67(4):1566–1574. doi: 10.1046/j.1471-4159.1996.67041566.x. [DOI] [PubMed] [Google Scholar]
  183. Trojanowski J. Q., Lee V. M. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J. 1995 Dec;9(15):1570–1576. doi: 10.1096/fasebj.9.15.8529836. [DOI] [PubMed] [Google Scholar]
  184. Vincent I. J., Davies P. A protein kinase associated with paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2878–2882. doi: 10.1073/pnas.89.7.2878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Vincent I. J., Davies P. Phosphorylation characteristics of the A68 protein in Alzheimer's disease. Brain Res. 1990 Oct 29;531(1-2):127–135. doi: 10.1016/0006-8993(90)90765-4. [DOI] [PubMed] [Google Scholar]
  186. Vincent I., Rosado M., Kim E., Davies P. Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau. J Neurochem. 1994 Feb;62(2):715–723. doi: 10.1046/j.1471-4159.1994.62020715.x. [DOI] [PubMed] [Google Scholar]
  187. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766–4770. doi: 10.1073/pnas.91.11.4766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Vulliet R., Halloran S. M., Braun R. K., Smith A. J., Lee G. Proline-directed phosphorylation of human Tau protein. J Biol Chem. 1992 Nov 5;267(31):22570–22574. [PubMed] [Google Scholar]
  189. Wang J. Z., Gong C. X., Zaidi T., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem. 1995 Mar 3;270(9):4854–4860. doi: 10.1074/jbc.270.9.4854. [DOI] [PubMed] [Google Scholar]
  190. Wang J. Z., Grundke-Iqbal I., Iqbal K. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res. 1996 Jun;38(2):200–208. doi: 10.1016/0169-328x(95)00316-k. [DOI] [PubMed] [Google Scholar]
  191. Watanabe A., Hasegawa M., Suzuki M., Takio K., Morishima-Kawashima M., Titani K., Arai T., Kosik K. S., Ihara Y. In vivo phosphorylation sites in fetal and adult rat tau. J Biol Chem. 1993 Dec 5;268(34):25712–25717. [PubMed] [Google Scholar]
  192. Wera S., Hemmings B. A. Serine/threonine protein phosphatases. Biochem J. 1995 Oct 1;311(Pt 1):17–29. doi: 10.1042/bj3110017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Wilson D. M., Binder L. I. Polymerization of microtubule-associated protein tau under near-physiological conditions. J Biol Chem. 1995 Oct 13;270(41):24306–24314. doi: 10.1074/jbc.270.41.24306. [DOI] [PubMed] [Google Scholar]
  194. Wischik C. M., Edwards P. C., Lai R. Y., Gertz H. N., Xuereb J. H., Paykel E. S., Brayne C., Huppert F. A., Mukaetova-Ladinska E. B., Mena R. Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Neurobiol Aging. 1995 May-Jun;16(3):409–431. doi: 10.1016/0197-4580(95)97327-d. [DOI] [PubMed] [Google Scholar]
  195. Wischik C. M., Edwards P. C., Lai R. Y., Roth M., Harrington C. R. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11213–11218. doi: 10.1073/pnas.93.20.11213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Wolozin B., Davies P. Alzheimer-related neuronal protein A68: specificity and distribution. Ann Neurol. 1987 Oct;22(4):521–526. doi: 10.1002/ana.410220412. [DOI] [PubMed] [Google Scholar]
  197. Wood J. G., Mirra S. S., Pollock N. J., Binder L. I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) Proc Natl Acad Sci U S A. 1986 Jun;83(11):4040–4043. doi: 10.1073/pnas.83.11.4040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Wood S. J., MacKenzie L., Maleeff B., Hurle M. R., Wetzel R. Selective inhibition of Abeta fibril formation. J Biol Chem. 1996 Feb 23;271(8):4086–4092. doi: 10.1074/jbc.271.8.4086. [DOI] [PubMed] [Google Scholar]
  199. Woodgett J. R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 1990 Aug;9(8):2431–2438. doi: 10.1002/j.1460-2075.1990.tb07419.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Wu J. M., Chen Y., An S., Perruccio L., Abdel-Ghany M., Carter T. H. Phosphorylation of protein tau by double-stranded DNA-dependent protein kinase. Biochem Biophys Res Commun. 1993 May 28;193(1):13–18. doi: 10.1006/bbrc.1993.1583. [DOI] [PubMed] [Google Scholar]
  201. Yamamoto H., Fukunaga K., Tanaka E., Miyamoto E. Ca2+- and calmodulin-dependent phosphorylation of microtubule-associated protein 2 and tau factor, and inhibition of microtubule assembly. J Neurochem. 1983 Oct;41(4):1119–1125. doi: 10.1111/j.1471-4159.1983.tb09060.x. [DOI] [PubMed] [Google Scholar]
  202. Yamamoto H., Saitoh Y., Fukunaga K., Nishimura H., Miyamoto E. Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly. J Neurochem. 1988 May;50(5):1614–1623. doi: 10.1111/j.1471-4159.1988.tb03051.x. [DOI] [PubMed] [Google Scholar]
  203. Yamamoto H., Saitoh Y., Yasugawa S., Miyamoto E. Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum. J Neurochem. 1990 Aug;55(2):683–690. doi: 10.1111/j.1471-4159.1990.tb04187.x. [DOI] [PubMed] [Google Scholar]
  204. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 1996 Aug 22;382(6593):685–691. doi: 10.1038/382685a0. [DOI] [PubMed] [Google Scholar]
  205. Yan S. D., Chen X., Schmidt A. M., Brett J., Godman G., Zou Y. S., Scott C. W., Caputo C., Frappier T., Smith M. A. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7787–7791. doi: 10.1073/pnas.91.16.7787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Yang L. S., Ksiezak-Reding H. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur J Biochem. 1995 Oct 1;233(1):9–17. doi: 10.1111/j.1432-1033.1995.009_1.x. [DOI] [PubMed] [Google Scholar]
  207. Yang S. D., Yu J. S., Shiah S. G., Huang J. J. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain. J Neurochem. 1994 Oct;63(4):1416–1425. doi: 10.1046/j.1471-4159.1994.63041416.x. [DOI] [PubMed] [Google Scholar]
  208. Yankner B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 1996 May;16(5):921–932. doi: 10.1016/s0896-6273(00)80115-4. [DOI] [PubMed] [Google Scholar]
  209. Yoshida H., Ihara Y. Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau. J Neurochem. 1993 Sep;61(3):1183–1186. doi: 10.1111/j.1471-4159.1993.tb03642.x. [DOI] [PubMed] [Google Scholar]
  210. Yoshida H., Ihara Y. Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau. J Neurochem. 1993 Sep;61(3):1183–1186. doi: 10.1111/j.1471-4159.1993.tb03642.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES